FLASHNEWS:

Day: October 12, 2022

Merck and Moderna Announce Exercise of Option by Merck for Joint Development and Commercialization of Investigational Personalized Cancer Vaccine

Companies on track to report data from the ongoing Phase 2 trial of mRNA-4157/V940 in combination with KEYTRUDA® as adjuvant therapy in high-risk melanoma in 4Q 2022 CAMBRIDGE, MA and RAHWAY, NJ / ACCESSWIRE / October 12, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Merck (NYSE:MRK), known […]

21Shares Cross-Lists World’s First Physically-Backed Bitcoin ETP on Nasdaq Dubai

21Shares’ entry into the Middle East provides investors in the market with access to the rapidly-growing asset class through Nasdaq Dubai DUBAI, UAE, October 12, 2022 – 21Shares AG (“21Shares”), part of parent company, 21.co, and the world’s largest issuer of cryptocurrency exchange traded products (ETPs), today announced its launch in the Middle East – introducing […]